Published in Chest on June 01, 1979
Dose-dependency of theophylline clearance and protein binding. Thorax (1981) 1.09
Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis. Br J Clin Pharmacol (1983) 1.03
Use of beta-blockade and hemoperfusion for acute theophylline poisoning. West J Med (1984) 0.76
Seizures from theophylline use. West J Med (1983) 0.75
A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest (1996) 2.55
Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea. Thorax (2008) 2.42
Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults. Medicine (Baltimore) (1972) 2.22
Cephalometric and computed tomographic predictors of obstructive sleep apnea severity. Am J Orthod Dentofacial Orthop (1995) 2.18
Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy. Am Rev Respir Dis (1991) 2.12
Increased receptor utilization: mechanism of cocaine potentiation. Nature (1968) 1.98
Long-term survival of patients with obstructive sleep apnea treated by uvulopalatopharyngoplasty or nasal CPAP. Chest (1994) 1.95
The relationship between obesity and craniofacial structure in obstructive sleep apnea. Chest (1995) 1.55
Respiratory muscle function during obstructive sleep apnea. Am Rev Respir Dis (1990) 1.46
Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins. Chest (1995) 1.45
Facial morphology and obstructive sleep apnea. Am J Orthod Dentofacial Orthop (1986) 1.40
A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax (1997) 1.39
Does carbon monoxide have a physiological function? Trends Pharmacol Sci (1991) 1.37
Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos (1999) 1.34
Adenosine inhibition of isolated rabbit ileum and antagonism by theophylline. J Pharmacol Exp Ther (1976) 1.29
How do prolonged wakefulness and alcohol compare in the decrements they produce on a simulated driving task? Accid Anal Prev (2001) 1.28
Mandibular advancement oral appliance therapy for obstructive sleep apnoea: effect on awake calibre of the velopharynx. Thorax (1999) 1.28
A cephalometric and electromyographic study of upper airway structures in the upright and supine positions. Am J Orthod Dentofacial Orthop (1994) 1.27
Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. J Pharmacol Exp Ther (1986) 1.22
Aerosol bronchodilators and hand-lung dyscoordination. Can Med Assoc J (1979) 1.21
Cephalometric comparisons of craniofacial and upper airway structure by skeletal subtype and gender in patients with obstructive sleep apnea. Am J Orthod Dentofacial Orthop (1996) 1.19
Three-dimensional CT reconstructions of tongue and airway in adult subjects with obstructive sleep apnea. Am J Orthod Dentofacial Orthop (1986) 1.19
Cephalometric and physiologic predictors of the efficacy of an adjustable oral appliance for treating obstructive sleep apnea. Am J Orthod Dentofacial Orthop (2001) 1.17
Cephalometric comparisons between Chinese and Caucasian patients with obstructive sleep apnea. Am J Orthod Dentofacial Orthop (2000) 1.15
Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate. J Pharmacol Exp Ther (1986) 1.14
Use of mechanical ventilation in adults with severe asthma. Can Med Assoc J (1984) 1.13
Endogenous opiates and chemical control of breathing in humans. Am Rev Respir Dis (1980) 1.12
Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep (1991) 1.11
Dose-dependency of theophylline clearance and protein binding. Thorax (1981) 1.09
Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis (1989) 1.08
Initial use of portable monitoring versus polysomnography to confirm obstructive sleep apnea in symptomatic patients: an economic decision model. Sleep Med (2010) 1.08
Treatment, airway and compliance effects of a titratable oral appliance. Sleep (2000) 1.04
The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Med (2007) 1.03
Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation. J Cardiovasc Pharmacol (1990) 1.02
Theophylline reassessed. Ann Intern Med (1984) 1.02
The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest (1992) 1.01
Cephalometric and demographic characteristics of obstructive sleep apnea: an evaluation with partial least squares analysis. Angle Orthod (1997) 1.00
Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea. Eur Respir J (2005) 1.00
Adenylate metabolism and adenosine formation in the heart. Am J Physiol (1972) 1.00
Ventilatory control in patients with hypoxemia due to obstructive lung disease. Am Rev Respir Dis (1979) 0.99
Three-dimensional upper airway computed tomography in obstructive sleep apnea. A prospective study in patients treated by uvulopalatopharyngoplasty. Am Rev Respir Dis (1991) 0.98
Mandibular posture during sleep in patients with obstructive sleep apnoea. Arch Oral Biol (1999) 0.98
Cigarette smoke inhalation patterns and bronchial reactivity. Thorax (1988) 0.97
Electrospray mass-spectrometric, spectrophotometric and electrochemical methods do not provide evidence for the binding of nitric oxide by pyocyanine at pH 7. Biochem J (1997) 0.97
Chemical control of ventilation and sleep arterial oxygen desaturation in patients with COPD. Am Rev Respir Dis (1980) 0.97
Respiratory dysrhythmias in patients with tardive dyskinesia. Chest (1994) 0.96
Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates. Can J Physiol Pharmacol (1989) 0.96
Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta (2002) 0.95
Upper airway measurements predict response to uvulopalatopharyngoplasty in obstructive sleep apnea. Laryngoscope (1990) 0.95
Inhibition of nitrovasodilators by pyocyanin and methylene blue is dissociated from nitric oxide formation. Can J Physiol Pharmacol (1994) 0.93
Theophylline pharmacokinetics and respiratory infections. Lancet (1978) 0.92
Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. Can J Physiol Pharmacol (1995) 0.92
Analysis of pyocyanin from Pseudomonas aeruginosa by adsorptive stripping voltammetry. J Pharmacol Toxicol Methods (1996) 0.91
A case report of obstructive sleep apnea in a patient with bipolar affective disorder. Can J Psychiatry (1985) 0.91
The bronchodilator effect of caffeine in adult asthmatics. Am Rev Respir Dis (1987) 0.91
Physiologic effects of chest percussion and postural drainage in patients with stable chronic bronchitis. Chest (1979) 0.91
Natural head posture, upper airway morphology and obstructive sleep apnoea severity in adults. Eur J Orthod (1998) 0.91
Chemiluminescence headspace-gas analysis for determination of nitric oxide formation in biological systems. Methods Enzymol (1996) 0.90
Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia. Can Respir J (2008) 0.90
Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta. J Pharmacol Exp Ther (1988) 0.90
Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 x g supernatant: biotransformation and nitric oxide formation. Can J Physiol Pharmacol (1991) 0.89
Outcome of thaw embryo transfer after cryopreservation of all embryos in patients at risk of ovarian hyperstimulation syndrome. Fertil Steril (1994) 0.89
Rapid, reliable and sensitive assay for warfarin using normal-phase high-performance liquid chromatography. J Chromatogr (1982) 0.89
Assembly of an inexpensive tail flick analgesia meter. J Pharmacol Methods (1981) 0.89
Reliable fifteen-minute assay for theophylline. Clin Biochem (1978) 0.89
Sleep-related breathing disorders. 4. Consequences of sleep disordered breathing. Thorax (1995) 0.88
Evidence for two adenine derivative receptors in rat ileum which are not involved in the nonadrenergic, noncholinergic response. Can J Physiol Pharmacol (1979) 0.88
Diacetylmorphine (heroin) hydrolases in human blood. Can J Physiol Pharmacol (1983) 0.88
Overnight home oximetry: can it identify patients with obstructive sleep apnea-hypopnea who have minimal daytime sleepiness? Respir Med (2003) 0.87
Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines. J Pharmacol Exp Ther (1989) 0.87
Studies on neplanocin A, new antitumor antibiotic. II. Structure determination. J Antibiot (Tokyo) (1981) 0.87
Effects of mandibular advancement on airway curvature and obstructive sleep apnoea severity. Eur Respir J (2004) 0.86
Anaesthetic management of emergency caesarean section followed by pulmonary embolectomy. Can J Anaesth (1989) 0.86
Unstrained chicken soup. Chest (1980) 0.86
Spectrophotometry of theophylline-7-acetic acid and theophylline. Clin Chem (1978) 0.86
The effect of the tongue retaining device on awake genioglossus muscle activity in patients with obstructive sleep apnea. Am J Orthod Dentofacial Orthop (1996) 0.86
Reversible reproductive dysfunction in men with obstructive sleep apnoea. Clin Endocrinol (Oxf) (1988) 0.86
The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can J Physiol Pharmacol (1997) 0.86
Obstructive sleep apnea subtypes by cluster analysis. Am J Orthod Dentofacial Orthop (1992) 0.86
Quantitation of nitric oxide formation from nitrovasodilator drugs by chemiluminescence analysis of headspace gas. J Pharmacol Methods (1991) 0.86
Associations among upper airway structure, body position, and obesity in skeletal Class I male patients with obstructive sleep apnea. Am J Orthod Dentofacial Orthop (1996) 0.85
Regional lung function in the presence of pleural symphysis. Am Rev Respir Dis (1980) 0.84
Nasal continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea in Hallermann-Streiff syndrome. Clin Pediatr (Phila) (1990) 0.84
Shortening of liquid chromatography columns for reduced retention time. Anal Chem (1983) 0.84
Heme oxygenase activity and immunohistochemical localization in bovine pulmonary artery and vein. J Cardiovasc Pharmacol (1997) 0.84
Mandibular posture during sleep in healthy adults. Arch Oral Biol (1998) 0.83
Simulated driving performance following prolonged wakefulness and alcohol consumption: separate and combined contributions to impairment. J Sleep Res (2000) 0.83
Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate. Drug Metab Dispos (1995) 0.83
Relationship between tissue damage and heme oxygenase expression in chorionic villi of term human placenta. Am J Physiol Heart Circ Physiol (2002) 0.83
Use of computerized tomography to evaluate bleeding after renal biopsy. Nephron (1980) 0.83
Potentiation of carbon monoxide-induced relaxation of rat aorta by YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole]. Can J Physiol Pharmacol (2000) 0.83
Theophylline clearance. Lack of effect of influenza vaccination and ascorbic acid. Am Rev Respir Dis (1984) 0.82
Silo-filler's disease. Can Med Assoc J (1978) 0.82